The medtech giant designed Tecnis PureSee IOL to deliver clarity of vision for patients. It says that 97% of patients report no very bothersome visual disturbances.

J&J plans to make Tecnis PureSee available for U.S. patients later this year.

The company said approval makes the system the first and only extended depth of focus (EDOF) IOL with no warning on loss of contrast sensitivity available in the U.S. It helps patients experience visual clarity and confidence with an extended range of vision through a single procedure.